VascTrac Peripheral Arterial Disease (PAD) Study

UnknownOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions
Peripheral Artery DiseaseIntermittent Claudication
Interventions
BEHAVIORAL

Physical activity levels

Patients with severely low physical activity levels will be notified to consult their physician.

Trial Locations (1)

94304

RECRUITING

VA Palo Alto Health Care System, Palo Alto

Sponsors
All Listed Sponsors
collaborator

W.L.Gore & Associates

INDUSTRY

collaborator

Abbott

INDUSTRY

collaborator

Cook Group Incorporated

INDUSTRY

collaborator

Boston Scientific Corporation

INDUSTRY

lead

Palo Alto Veterans Institute for Research

OTHER

NCT03048890 - VascTrac Peripheral Arterial Disease (PAD) Study | Biotech Hunter | Biotech Hunter